12^th International Conference on ^{Genomics and Molecular Biology} April 15-17, 2019 Berlin, Germany

Patrizia Zavattari, received the M.Sc. degree in Biological Sciences at Pisa University (Italy) and the PhD at Cagliari University (Italy). She is Associate Professor of Experimental Biology and Genetics at Cagliari University, teaching in the Faculties of Biology, Pharmacy and Medicine. She is the Head of a Molecular Biology, Genomics and Epigenomics Laboratory.

Her research interests are mainly focused on molecular oncology and complex traits. She worked both abroad (Paris, Oxford, Cambridge, Philadelphia) and in Italy (Milan, Novara). She is co-author of about forty publications. Since 2011 she is Review Editor of Frontiers and she reviews for various scientific journals.

Henry M. Sobell completed his studies at Brooklyn Technical High School (1948-1952), Columbia College (1952-1956), and the University of Virginia School of Medicine (1956-1960). Instead of practicing clinical medicine, he then went to the Massachusetts Institute of Technology (MIT) to join Professor Alexander Rich in the Department of Biology (1960-1965), where, as a Helen Hay Whitney Postdoctoral Fellow, he learned the technique of single crystal X-ray analysis. He then joined the Chemistry Department at the University of Rochester, having been subsequently jointly appointed to both the Chemistry and Molecular Biophysics departments (the latter at the University of Rochester School of Medicine and Dentistry), becoming a full tenured Professor in both departments (1965-1993). He is now retired and living in the Adirondacks in New York, USA.

Henry M. Sobell currently works at the Department of Chemistry, University of Rochester. Henry does research in Structural Biology, Molecular Biology and Genetics. His current project is "Premeltons in DNA"

Jane Xiao has obtained her PhD in Analytical Chemistry at University of Wales Swansea, UK. She is a Co-Founder and Senior Director in Biologics Characterization at Axcel BioPartners. Prior to that, she served as Director at Oncobiologics, Head of a proteomics lab at Johnson & Johnson and Senior Scientist at Merck.

For the last 15 years she has worked for the pharmaceutical industry leading analytical method development for protein characterization, biomarker development in early phase clinical trials, biosimilar development for similarity assessment and comparability assessment.